bismuth has been researched along with Acute Lymphoid Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Ejeh, F; Boyd, AW; Charmsaz, S; Cooper, LT; Lackmann, M; Lee, FT; Miller, KJ; Moore, AS; Scott, AM; Smith, FM; Stringer, BW; Stylianou, C; Woronicz, J; Yarranton, GT; Yeadon, TM | 1 |
1 other study(ies) available for bismuth and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
EphA3 as a target for antibody immunotherapy in acute lymphoblastic leukemia.
Topics: Animals; Antibodies, Monoclonal; Bismuth; Cell Line, Tumor; Humans; Immunotherapy; Mice; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptor, EphA3; Xenograft Model Antitumor Assays | 2017 |